Rising Road Accidents And Burn Cases Fuel Growth In Hypertrophic And Keloid Scar Treatment Market: The Driving Engine Behind Hypertrophic And Keloid Scar Treatment Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Hypertrophic And Keloid Scar Treatment Market Size Growth Forecast: What to Expect by 2025?
In recent years, the market size for the treatment of hypertrophic and keloid scars has seen significant growth. The market, which stood at $7.72 billion in 2024, is projected to surge to $8.51 billion in 2025, recording a compound annual growth rate (CAGR) of 10.3%. This growth throughout the historical period can be traced back to the increased occurrence of hypertrophic and keloid scars, as well as advancements in scar evaluation. Additionally, the rising adoption of topical treatments, surgeries, and other invasive procedures coupled with the growing patient demand for scar reduction also contributed to this expansion.

How Will the Hypertrophic And Keloid Scar Treatment Market Size Evolve and Grow by 2029?
The market size for the treatment of hypertrophic and keloid scars is predicted to experience a significant expansion in the coming years, reaching a size of "$12.51 billion by 2029 and demonstrating a Compound Annual Growth Rate (CAGR) of 10.1%. Factors contributing to this growth during the forecasted period include new developments in minimally invasive procedures, improvements in scar revision methods, a rising focus on combined therapeutic approaches, growing consciousness and early action, along with popular global aesthetic trends. Key trending aspects within this period encompass emerging injectable therapy options, synergistic effect-focused combination therapies, patient-centered methodologies, novel scar evaluation technologies, and the utilization of telemedicine for check-ups and consultations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

What Drivers Are Propelling the Growth of Hypertrophic And Keloid Scar Treatment Market Forward?
The hypertrophic and keloid scar treatment market is poised for growth due to an expected rise in road accidents and burn incidents. Road accidents, which involve at least one vehicle and individuals on the road, along with burn cases, necessitate immediate attention and suitable interventions for prevention and effective treatment. Hypertrophic and keloid scar treatments, which minimize the size and rigidity of scars, are utilized for treating road accident victims. The rise in road accident numbers and burn cases have a direct impact on the hypertrophic and keloid scar treatment market's growth. For instance, the National Highway Traffic Safety Administration reported that approximately 9,560 individuals lost their lives in car crashes during the first three months of 2022, which is roughly a 7% increase compared to the same period in 2021, when fatalities were 8,935. Moreover, the death rate increased from an anticipated rate of 1.25 deaths per 100 million vehicle miles in the first quarter of 2021 to 1.27 deaths per 100 million vehicle miles in the first quarter of 2022. Consequently, the surge in road accidents and burn cases is likely to act as a catalyst for the hypertrophic and keloid scar treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp

Which Emerging Trends Are Transforming the Hypertrophic And Keloid Scar Treatment Market in 2025?
The hypertrophic and keloid scar treatment market is seeing innovation in silicone-based solutions. In April 2023, UK-based Scar Erase introduced silicone strips made of 3mm medical-grade silicone, designed for treating hypertrophic, keloid, and post-surgical scars. These strips hydrate the skin and create an optimal healing environment, significantly reducing scar texture, color, and height in a discreet, at-home format.

What Are the Key Segments in the Hypertrophic And Keloid Scar Treatment Market?
The hypertrophic and keloid scar treatment market covered in this report is segmented -

1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users

Subsegments:
1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy
2) By Surgical Excision: Simple Excision, Excision With Skin Grafting
3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings
4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids
5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments
6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil
7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10692&type=smp

Who Are the Key Players Shaping the Hypertrophic And Keloid Scar Treatment Market's Competitive Landscape?
Major companies operating in the hypertrophic and keloid scar treatment market include Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Revitol Corporation Inc., Scarfade, Biodermis, Mederma, Silagen

What Geographic Markets Are Powering Growth in the Hypertrophic And Keloid Scar Treatment Market?
North America was the largest region in the hypertrophic and keloid scar treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10692

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.